Notable epigenetic role of hyperhomocysteinemia in atherogenesis

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Zhou, Shuyu ^a   Zhang, Zhizhong ^a   Xu, Gelin ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Atherosclerosis; DNA methylation; Epigenetics; Hyperhomocysteinemia

Indexed keywords

DNA; HISTONE; HOMOCYSTEINE;

ATHEROGENESIS; ATHEROSCLEROSIS; DNA METHYLATION; EPIGENETICS; GENETIC ANALYSIS; GENETIC REGULATION; HISTONE MODIFICATION; HUMAN; HYPERHOMOCYSTEINEMIA; REVIEW; ANIMAL; COMPLICATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PROTEIN PROCESSING;

ANIMALS; ATHEROSCLEROSIS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; HYPERHOMOCYSTEINEMIA; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84906928098     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-134     Document Type: Review

References (76)

1. An operational definition of epigenetics. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A, Genes Dev 2009 23 781 783
2. DNA methylation. Singal R, Ginder GD, Blood 1999 93 4059 4070
3. CpG-rich islands and the function of DNA methylation. Bird AP, Nature 1985 321 209 213
4. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Kerkel K, Spadola A, Yuan E, Kosek J, Jiang L, Hod E, Li K, Murty VV, Schupf N, Vilain E, Nat Genet 2008 40 904 908
5. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Shoemaker R, Deng J, Wang W, Zhang K, Genome Res 2010 20 883 889
6. DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Bell JT, Pai AA, Pickrell JK, Gaffney DJ, Pique-Regi R, Degner JF, Gilad Y, Pritchard JK, Genome Biol 2011 12 10
7. SNPs located at CpG sites modulate genome-epigenome interaction. Arnett DK, Epigenetics 2013 8 802 806
8. Unraveling the DNA methylome of atherosclerosis. Zaina S, Curr Opin Lipidol 2014 25 148 153
9. Can reduced folic acid and vitamin B12 levels cause deficient DNA methylation producing mutations which initiate atherosclerosis? Newman P, Med Hypotheses 1999 53 421 424
10. From genotype to phenotype in human atherosclerosis-recent findings. Holdt LM, Teupser D, Curr Opin Lipidol 2013 24 410
11. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. De Bree A, Verschuren WM, Kromhout D, Kluijtmans L, Blom HJ, Pharmacol Rev 2002 54 599 618
12. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. Collaboration HS, JAMA 2002 288 2015 2022
13. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Wald DS, Law M, Morris JK, BMJ 2002 325 1202
14. Homocysteine and atherothrombosis. Epstein FH, Welch GN, Loscalzo J, N Engl J Med 1998 338 1042 1050
15. Pathogenesis of vascular disease in hyperhomocysteinaemia. Domagala TB, Undas A, Libura M, Szczeklik A, J Cardiovasc Risk 1998 5 239 247
16. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Faraci FM, Lentz SR, Stroke 2004 35 345 347
17. The metabolism of homocysteine: pathways and regulation. Finkelstein J, Eur J Pediatr 1998 157 40 S44
18. The role of S-adenosylhomocysteine in the biological utilization of S-adenosylmethionine. Cantoni G, Prog Clin Biol Res 1985 198 47 65
19. Perturbation of biochemical transmethylations by 3-deazaadenosine in vivo. Chiang PK, Cantoni GL, Biochem Pharmacol 1979 28 1897 1902
20. S-Adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of L-methionine, L-homocystein, and adenosine. Hoffman D, Marion D, Cornatzer W, Duerre J, J Biol Chem 1980 255 10822 10827
21. Relationship between tissue levels of S-adenosylmethionine, S-adenosylhomocysteine, and transmethylation reactions. Hoffman DR, Cornatzer WE, Duerre JA, Can J Biochem 1979 57 56 64
22. Homocysteine metabolism. Selhub J, Annu Rev Nutr 1999 19 217 246
23. Homocysteine Hypothesis for Atherothrombotic Cardiovascular Disease: Not Validated. Kaul S, Zadeh AA, Shah PK, J Am Coll Cardiol 2006 48 914 923
24. Homocysteine and cardiovascular disease: a review of the evidence. Wierzbicki AS, Diab Vasc Dis Res 2007 4 143 149
25. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers G, den Heijer M, Kluijtmans L, Van Den Heuvel LP, Nat Genet 1995 10 111 113
26. Genetics of homocysteine metabolism and associated disorders. Brustolin S, Giugliani R, Félix T, Braz J Med Biol Res 2010 43 1 7
27. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Weiss N, Keller C, Hoffmann U, Loscalzo J, Vasc Med 2002 7 227 239
28. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ, J Biol Chem 2000 275 29318 29323
29. Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/ S-adenosylhomocysteine in peripheral arterial occlusive disease. Loehrer FM, Tschöpl M, Angst CP, Litynski P, Jäger K, Fowler B, Haefeli WE, Atherosclerosis 2001 154 147 154
30. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Castro R, Rivera I, Struys EA, Jansen E, Ravasco P, Camilo ME, Blom HJ, Jakobs C, de Almeida IT, Clin Chem 2003 49 1292 1296
31. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. Lund G, Andersson L, Lauria M, Lindholm M, Fraga MF, Villar-Garea A, Ballestar E, Esteller M, Zaina S, J Biol Chem 2004 279 29147 29154
32. Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Devlin AM, Arning E, Bottiglieri T, Faraci FM, Rozen R, Lentz SR, Blood 2004 103 2624 2629
33. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells. Ehrlich M, Gama-Sosa MA, Huang L-H, Midgett RM, Kuo KC, McCune RA, Gehrke C, Nucleic Acids Res 1982 10 2709 2721
34. CpG islands as gene markers in the vertebrate nucleus. Bird AP, Trends Genet 1987 3 342 347
35. Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3. Aoyama T, Okamoto T, Nagayama S, Nishijo K, Ishibe T, Yasura K, Nakayama T, Nakamura T, Toguchida J, J Biol Chem 2004 279 28789 28797
36. DNA methylation: the nuts and bolts of repression. Miranda TB, Jones PA, J Cell Physiol 2007 213 384 390
37. Epigenetics and atherosclerosis. Turunen MP, Aavik E, Ylä-Herttuala S, Biochim Biophys Acta (BBA)-General Subjects 2009 1790 886 891
38. Epigenetics in atherosclerosis and inflammation. Wierda RJ, Geutskens SB, Jukema JW, Quax P, van den Elsen PJ, J Cell Mol Med 2010 14 1225 1240
39. Epigenetic Modifications Basic Mechanisms and Role in Cardiovascular Disease. Handy DE, Castro R, Loscalzo J, Circulation 2011 123 2145 2156
40. Atherosclerosis: an epigenetic balancing act that goes wrong. Lund G, Zaina S, Curr Atheroscler Rep 2011 13 208 214
41. Environmental exposures, epigenetics and cardiovascular disease. Baccarelli A, Ghosh S, Curr Opin Clin Nutr Metab Care 2012 15 323
42. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Laukkanen MO, Mannermaa S, Hiltunen MO, Aittomäki S, Airenne K, Jänne J, Ylä-Herttuala S, Arterioscler Thromb Vasc Biol 1999 19 2171 2178
43. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Hiltunen MO, Turunen MP, Häkkinen TP, Rutanen J, Hedman M, Mäkinen K, Turunen AM, Aalto-Setalä K, Ylä-Herttuala S, Vasc Med 2002 7 5 11
44. Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. Yideng J, Jianzhong Z, Ying H, Juan S, Jinge Z, Shenglan W, Xiaoqun H, Shuren W, DNA Cell Biol 2007 26 603 611
45. Hyperhomocysteinemiamediated DNA Hypomethylation and its Potential Epigenetic Role in Rats. Jiang Y, Sun T, Xiong J, Cao J, Li G, Wang S, Acta Biochim Biophys Sin 2007 39 657 667
46. Increased plasma S-adenosyl-homocysteine levels induce the proliferation and migration of VSMCs through an oxidative stress-ERK1/2 pathway in apoE-/-mice. Luo X, Xiao Y, Song F, Yang Y, Xia M, Ling W, Cardiovasc Res 2012 95 241 250
47. Identification of Authentic Estrogen Receptor in Cultured Endothelial Cells A Potential Mechanism for Steroid Hormone Regulation of Endothelial Function. Venkov CD, Rankin AB, Vaughan DE, Circulation 1996 94 727 733
48. Vascular actions of estrogens: functional implications. Miller VM, Duckles SP, Pharmacol Rev 2008 60 210 241
49. A comparative study on pathogenic effects of homocysteine and cysteine on atherosclerosis. Su J, Wang S, Hunag Y, Jinag Y, Wei Sheng Yan Jiu 2009 38 43 46
50. Hyperhomocysteinemia, DNA methylation and vascular disease. Jamaluddin MS, Yang X, Wang H, Clin Chem Lab Med 2007 45 1660 1666
51. Homocysteine: an important risk factor for atherosclerotic vascular disease. Duell PB, Malinow MR, Curr Opin Lipidol 1997 8 28 34
52. Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene. Zhang J, Liu J, Li Z, Wang L, Jiang Y, Wang S, Chin Med J Beijing Engl Ed 2007 120 2132
53. Homocysteine-induced hypermethylation of DDAH2 promoter contributes to apoptosis of endothelial cells. Jia SJ, Lai YQ, Zhao M, Gong T, Zhang B, Die Pharmazie-An Int J Pharm Sci 2013 68 282 286
54. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, Pai A, John S, Smith RS, Hum Mol Genet 2001 10 433
55. Folate and ApoE DNA methylation induced by homocysteine in human monocytes. Yi-Deng J, Tao S, Hui-Ping Z, Jian-Tuan X, Jun C, Gui-Zhong L, Shu-Ren W, DNA Cell Biol 2007 26 737 744
56. Homocysteine-mediated PPAR, γ DNA methylation and its potential pathogenic mechanism in monocytes. Yideng J, Zhihong L, Jiantuan X, Jun C, Guizhong L, Shuren W, DNA Cell Biol 2008 27 143 150
57. Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-κB/DNA Methyltransferase 1 in Apolipoprotein E-Deficient Mice. Wang J, Jiang Y, Yang A, Sun W, Ma C, Ma S, Gong H, Shi Y, Wei J, Bio Res Open Access 2013 2 118 127
58. Homocysteine-mediated cholesterol efflux via ABCA1 and ACAT1 DNA methylation in THP-1 monocyte-derived foam cells. Liang Y, Yang X, Ma L, Cai X, Wang L, Yang C, Li G, Zhang M, Sun W, Jiang Y, Acta Biochim Biophys Sin 2013 45 220 228
59. Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia? Zaina S, Lindholm MW, Lund G, J Nutr 2005 135 5 8
60. Detection of altered global DNA methylation in coronary artery disease patients. Sharma P, Kumar J, Garg G, Kumar A, Patowary A, Karthikeyan G, Ramakrishnan L, Brahmachari V, Sengupta S, DNA Cell Biol 2008 27 357 365
61. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Sharma P, Senthilkumar R, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A, Sengupta S, Lipids Health Dis 2006 5 1 19
62. Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Ingrosso D, Perna AF, Biochim Biophys Acta (BBA)-General Subjects 2009 1790 892 899
63. Human DNA methylomes at base resolution show widespread epigenomic differences. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Nature 2009 462 315 322
64. Chromatin modifications and their function. Kouzarides T, Cell 2007 128 693 705
65. The diverse functions of histone lysine methylation. Martin C, Zhang Y, Nat Rev Mol Cell Biol 2005 6 838 849
66. The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression. Jeppesen P, Turner BM, Cell 1993 74 281 289
67. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Braunstein M, Rose A, Holmes S, Allis C, Broach J, Genes Dev 1993 7 592 604
68. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T, Nature 2001 410 116 120
69. The role of redox signaling in epigenetics and cardiovascular disease. Kim GH, Ryan JJ, Archer SL, Antioxid Redox Signal 2013 18 1920 1936
70. Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis. Findeisen HM, Kahles FK, Bruemmer D, Curr Atheroscler Rep 2013 15 1 8
71. Atherogenic factors and their epigenetic relationships. Fernandez AZ, Siebel AL, El-Osta A, Int J Vasc Med 2010 2010 http://www.hindawi.com/journals/ijvm/2010/437809/
72. Global protein and histone arginine methylation are affected in a tissue-specific manner in a rat model of diet-induced hyperhomocysteinemia. Esse R, Florindo C, Imbard A, Rocha M, de Vriese A, Smulders Y, Teerlink T, Tavares de Almeida I, Castro R, Blom H, Biochim Biophys Acta (BBA)-Mol Basis Dis 2013 1832 1708 1714
73. Protein arginine hypomethylation in a mouse model of cystathionine β-synthase deficiency. Esse R, Imbard A, Florindo C, Rocha M, de Vriese A, Smulders Y, Teerlink T, Tavares de Almeida I, Castro R, Blom H, FASEB J 2014 28 2686 2695
74. Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes. Jiang Y, Jiang J, Xiong J, Cao J, Li N, Li G, Wang S, J Exp Biol 2008 211 911 920
75. Homocysteine levels impact directly on epigenetic reprogramming in astrocytes. Jin Y, Amaral A, McCann A, Brennan L, Neurochem Int 2011 58 833 838
76. Folic acid effects on S-adenosylmethionine, S-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. Pizzolo F, Blom HJ, Choi SW, Girelli D, Guarini P, Martinelli N, Stanzial AM, Corrocher R, Olivieri O, Friso S, J Am Coll Nutr 2011 30 11 18